IDiyas

For the Inventor, By the Inventor

Old Bridge, NJ, United States of America

David L Hughes

USPTO Granted Patents = 13

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Scotch Plains, NJ (US) (1987)
  • Old Bridge, NJ (US) (1990 - 2001)
  • Hoboken, NJ (US) (2001)

Company Filing History:

goldMedal13 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1987-2001

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6333435 - Process of synthesizing binaphthyl derivatives (2001-12-25),
2. 6262268 - Process and intermediates to a tetrahydro-[1,8]-naphthyridine (2001-07-17),
3. 5892082 - Process for the preparation of dimethyl titanocene (1999-04-06),
4. 5665882 - Pyridyl ethylation of lactams (1997-09-09),
5. 5552521 - Process for preparing certain aza cyclohexapeptides (1996-09-03),
6. 5340927 - Process for the preparation of 2-diazo-3-trisubstituted silyloxy (1994-08-23),
7. 5312923 - Process for preparing fibrinogen receptor antagonists (1994-05-17),
8. 5206373 - Process for preparing fibrinogen receptor antagonists (1993-04-27),
9. 5157122 - Process for the preparation of 3-unsubstituted indoles using methane (1992-10-20),
10. 5126456 - 7-chloroquinaldine synthesis (1992-06-30),
11. 5070022 - Enzymic process for preparing leukotriene antagonists (1991-12-03),
12. 4894450 - Process for 2-(aminoalkylthio) carbapenems (1990-01-16),
13. 4654433 - Process for the preparation of esters of amino acids (1987-03-31),

Title: The Innovative Contributions of David L Hughes

Introduction

David L Hughes is a prominent inventor based in Old Bridge, NJ (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of complex compounds. With a total of 13 patents to his name, Hughes has established himself as a key figure in the pharmaceutical industry.

Latest Patents

Hughes' latest patents include a process for synthesizing binaphthyl derivatives and a novel method for preparing 3-(5,6,7,8-tetrahydro-[1,8]-naphthyridin-2-yl)-propylamine. The latter is particularly noteworthy as it is useful in the synthesis of αv integrin receptor antagonists. These innovations demonstrate his commitment to advancing chemical processes and developing new therapeutic agents.

Career Highlights

Hughes is currently employed at Merck & Company, Inc., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also had a broader impact on the field of medicinal chemistry.

Collaborations

Throughout his career, Hughes has collaborated with notable colleagues, including Dalian Zhao and John Y Chung. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

David L Hughes exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts highlight the importance of research and development in creating new solutions for healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…